Profile
Master of Fate
Master of Fate
Megan Scudellari | Jul 1, 2013
While tracing the tricky and sometimes surprising paths of multipotent cells in the skin, mammary gland, and heart, Cédric Blanpain has repeatedly turned the stem cell field on its head.
 
In Evolution's Garden
In Evolution's Garden
Megan Scudellari | Jun 1, 2013
Raising one evolutionary question after another, Brandon Gaut has harvested a crop of novel findings about how plant genomes evolve.
The Organist
The Organist
Megan Scudellari | May 1, 2013
When molecular biology methods failed her, Sangeeta Bhatia turned to engineering and microfabrication to build a liver from scratch.
Up, Up, and Array
Up, Up, and Array
Megan Scudellari | Apr 1, 2013
By scrutinizing gene expression profiles instead of individual oncogenes, Todd Golub launched a powerful platform for diagnosing, classifying, and treating cancer.
Tough Bugger
Tough Bugger
Megan Scudellari | Mar 1, 2013
Fearless cockroach hunter Coby Schal investigates how insects communicate via chemical cues, then subverts those signals for pest control.
Immune to Failure
Immune to Failure
Karen Hopkin | Feb 1, 2013
With dogged persistence and an unwillingness to entertain defeat, Bruce Beutler discovered a receptor that powers the innate immune response to infections—and earned his share of a Nobel Prize.
Going Boldly Forth
Going Boldly Forth
Karen Hopkin | Jan 1, 2013
Gregory Hannon believes in taking risks—an approach that’s enabled him to make exciting new discoveries in the world of small RNAs.
An Epi Phenomenon
An Epi Phenomenon
Karen Hopkin | Dec 1, 2012
While exploring the genetics of a rare type of tumor, Stephen Baylin discovered an epigenetic modification that occurs in most every cancer—a finding he’s helping bring to the clinic.
The Road Less Traveled
The Road Less Traveled
Megan Scudellari | Nov 1, 2012
First, Aravinda Chakravarti drew a map of how scientists might unravel the genetics of complex disease. Then he blazed the trail.
(Re)Programming Director
Karen Hopkin | Oct 1, 2012
Unwilling to accept the finality of terminal differentiation, Helen Blau has honed techniques that showcase the flexibility of cells to adopt different identities.